MAI Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $529K | Buy |
1,007
+114
| +13% | +$59.9K | ﹤0.01% | 805 |
|
|
2025
Q1 | $566K | Sell |
893
-2,318
| -72% | -$1.47M | ﹤0.01% | 760 |
|
|
2024
Q4 | $2.29M | Sell |
3,211
-570
| -15% | -$406K | 0.02% | 452 |
|
|
2024
Q3 | $3.97M | Sell |
3,781
-250
| -6% | -$263K | 0.04% | 283 |
|
|
2024
Q2 | $4.24M | Buy |
4,031
+36
| +0.9% | +$37.8K | 0.04% | 278 |
|
|
2024
Q1 | $3.85M | Buy |
3,995
+2,845
| +247% | +$2.74M | 0.04% | 285 |
|
|
2023
Q4 | $1.01M | Sell |
1,150
-23
| -2% | -$20.2K | 0.01% | 449 |
|
|
2023
Q3 | $965K | Buy |
1,173
+45
| +4% | +$37K | 0.01% | 430 |
|
|
2023
Q2 | $811K | Buy |
1,128
+161
| +17% | +$116K | 0.01% | 470 |
|
|
2023
Q1 | $795K | Buy |
967
+136
| +16% | +$112K | 0.01% | 474 |
|
|
2022
Q4 | $600K | Buy |
831
+48
| +6% | +$34.6K | 0.01% | 551 |
|
|
2022
Q3 | $539K | Buy |
783
+179
| +30% | +$123K | 0.01% | 513 |
|
|
2022
Q2 | $357K | Buy |
604
+294
| +95% | +$174K | 0.01% | 619 |
|
|
2022
Q1 | $217K | Sell |
310
-54
| -15% | -$37.8K | ﹤0.01% | 776 |
|
|
2021
Q4 | $230K | Buy |
+364
| New | +$230K | ﹤0.01% | 755 |
|